TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups March 21, 1986
TCL Archive Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines November 4, 1994
